With the advent of video laryngoscopes, much of how intubations are done has changed. Medical personnel are now able to get a better view of airway structures thanks to the help of videolaryngoscopy.
Astronauts at the International Space Station are dependent upon telemedicine for all kinds of illness. However, according to Dr. Shannan Moynihan, the deputy chief of space and occupational medicine from the NASA Johnson Space Centre, although effective, telemedicine has its limits.
Artios Pharma, a U.K. based company in Cambridge, has raised $84 million to take DNA damage response (DDR) programs to the next level of clinical proof of concept.
Fitbit has generated yet another mHealth partnership in its bidding to make the fitness wearables a major component in connected health programs.
Neurodegenerative diseases are plenty in number, but to find the ultimate research is still ongoing worldwide. One company involved in this process is Suven Life Sciences. They have discovered novel chemical entities responsible for the treatment of neurodegenerative diseases, which were claimed for patenting.
HitGen and Merck have updated their licensing agreement to a full-fledged drug discovery collaboration in order to screen DNA-encoded libraries for new small-molecule assets.
Janssen Korea becomes yet another drugmaker to shut its Hyangnam plant in Hwaseong, South Korea, by 2021, stranding an uncounted number of employees.
Resolve Greater Rochester and Rochester Institute of Technology researchers got together to build a new app that helps evaluate a person’s physical and mental health.
Natural Cycles, an app which includes both a contraceptive and a fertility tracker, has again become the target of a regulatory investigation due to various claims made in its advertisements.
WebMD, an Internet Brands company, announced its purchase of Vitals Consumer Services Division from Mdx Medical in a period of two months since its earlier acquisition.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.